Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients

Overview of attention for article published in JACC, October 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 3 blogs
twitter: 42 X users

facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 197 Dimensions

Readers on

mendeley: 162 Mendeley

Summary Blogs X Facebook Research highlights Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

Run-in periods in clinical trials: What can we ACHIEVE?

Blog - NephJC, 13 Sep 2021

#NephTrials ChatTuesday Sep 28th 9 pm EasternAfter cluster RCTs and pragmatic trials, we will discuss the role of run-in…

December 2018

Last month in Nephrology, 28 Dec 2018

1 Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance…

Spironolactone Revisited

Renal Fellow Network, 04 Aug 2014

As a renal fellow, I have found myself reaching for spironolactone more and more. It is very helpful when treating the patient…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.